Provectus Biopharmaceuticals, Inc. (PVCT)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.05
- As of
Kresmion compiles this page from PVCT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-13.
See the full PVCT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PVCT on one page. Preview it with sample data, then open it live with a free account.
Preview the PVCT dossierActive events for PVCT
- lowEarnings above estimates
Q3-2012: EPS $-0.02 vs $-0.0306 estimate, +0.01 on a near-zero consensus
- lowEarnings above estimates
Q4-2012: EPS $-0.02 vs $-0.0306 estimate, +0.01 on a near-zero consensus
FREE, NO ACCOUNT
Every event on PVCT, as it fires
New filings, 13F moves and cross asset events on PVCT land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, PVCT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
PVCT's 10-Q filed Aug 13, 2026 states:
These circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on PVCT
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in PVCT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on PVCT in the last 180 days.
Upstream: SEC EDGAR filings for PVCT
Kresmion, "PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) institutional holdings and SEC filings", data as of 2026-08-13, https://kresmion.com/research/PVCT. Upstream data: SEC EDGAR filings for PVCT.
Link to this data (HTML):
<a href="https://kresmion.com/research/PVCT">PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow PVCT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to PVCT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.